Based on the underlying mechanisms, tumor-induced hypercalcemia can result from osteolytic bone destruction, excessive secretion of PTHrP, or increased activation of 1,25-dihydroxyvitamin D. These mechanisms are generally associated with suppressed PTH levels. This evidence concerns the gene PTH and Hypercalcemia.